Cell-penetrating RNAs: New keys to the castle

Molecular Therapy

Volumn 20, Issue 2, 2012, Pages 251-253

  Burke, Donald H ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; CELL PENETRATING PEPTIDE; DIGITONIN; PLASMID DNA; SMALL INTERFERING RNA;

CELL MEMBRANE PERMEABILITY; CELL SPECIFICITY; CELL SURFACE; CELL TYPE; DNA LIBRARY; DNA SEQUENCE; DRUG TARGETING; GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; HUMAN; INTERNALIZATION; INTRACELLULAR TRANSPORT; NONHUMAN; NOTE; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE TRANSPORT; PROTEIN RNA BINDING; PROTEIN TRANSPORT; RECEPTOR AFFINITY; RNA PROCESSING;

EID: 84856540532     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.306     Document Type: Note

References (16)

1. Griffith, F (1928). The significance of pneumococcal types. J Hyg 27: 113-159.
2. Avery, O, Macleod, C and McCarty, M (1944). Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from Pneumococcus Type III. J Exp Med 79: 137-158.
3. Magalhäes, MLB, Byrom, M, Yan, A, Kelly, L, Li, N, Furtado, T et al. A general RNA motif for cellular transfection. Mol Ther, in press.
4. Morris, K, Jensen, K, Julin, C, Weil, M and Gold, L (1998). High affinity ligands from in vitro selection: complex targets. Proc Natl Acad Sci USA 95: 2902-2907. (Pubitemid 28135827)
5. Bayrac, AT, Sefah, K, Parekh, P, Bayrac, C, Gulbakan, B, Oktem, HA et al. (2011). In vitro selection of DNA aptamers to glioblastoma multiforme. ACS Chem Neurosci 2: 175-181.
6. Van Simaeys, D, López-Colón, D, Sefah, K, Sutphen, R, Jimenez, E and Tan, W (2010). Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX. PLoS One 5: e13770.
7. Cerchia, L, Esposito, C, Jacobs, A, Tavitian, B and de Franciscis, V (2009). Differential SELEX in human glioma cell lines. PLoS One 24: e7971.
8. Pastor, F, Kolonias, D, Giangrande, P and Gilboa, E (2010). Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay. Nature 465: 227-230.
9. Ni, X, Zhang, Y, Ribas, J, Chowdhury, WH, Castanares, M, Zhang, Z et al. (2011). Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts. J Clin Invest 121: 2383-2390.
10. Thiel, K and Giangrande, P (2010). Intracellular delivery of RNA-based therapeutics using aptamers. Ther Deliv 1: 849-861.
11. Li, N, Nguyen, H, Byrom, M and Ellington, AD (2011). Inhibition of cell proliferation by an anti-EGFR aptamer. PLoS One 6: e20299.
12. Wheeler, LA, Trifonova, R, Vrbanac, V, Basar, E, McKernan, S, Zu, Z et al. (2011). Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras. J Clin Invest 121: 2401-2412.
13. Zhou, J, Li, H, Zhang, J, Piotr, S and Rossi, J (2011). Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery. J Vis Exp 23 June pii: 2954.
14. Zhou, J and Rossi, J (2011). Aptamer-targeted RNAi for HIV-1 therapy. Methods Mol Biol 721: 355-371.
15. Frankel, A and Pabo, C (1988). Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55: 1189-1193. (Pubitemid 19020071)
16. Green, M and Loewenstein, P (1988). Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55: 1179-1188. (Pubitemid 19020070)